Business Description
Ferozsons Laboratories Ltd
ISIN : PK0005201014
Compare
Compare
Traded in other countries / regions
FEROZ.Pakistan IPO Date
1960-09-08Description
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and oncology. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. It operates in three segments namely Ferozsons; BF Biosciences; and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.25 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.51 | |||||
| Debt-to-EBITDA | 2.56 | |||||
| Interest Coverage | 2.98 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 2.35 | |||||
| Beneish M-Score | -1.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22.6 | |||||
| 3-Year EBITDA Growth Rate | 6 | |||||
| 3-Year EPS without NRI Growth Rate | -13.5 | |||||
| 3-Year FCF Growth Rate | -103.3 | |||||
| 3-Year Book Growth Rate | 7.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.53 | |||||
| 9-Day RSI | 50.15 | |||||
| 14-Day RSI | 50.21 | |||||
| 6-1 Month Momentum % | 21.99 | |||||
| 12-1 Month Momentum % | 55.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.49 | |||||
| Quick Ratio | 0.69 | |||||
| Cash Ratio | 0.15 | |||||
| Days Inventory | 179.75 | |||||
| Days Sales Outstanding | 42.07 | |||||
| Days Payable | 123.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 21.6 | |||||
| Shareholder Yield % | -6.69 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.8 | |||||
| Operating Margin % | 9.42 | |||||
| Net Margin % | 2.72 | |||||
| FCF Margin % | -11.57 | |||||
| ROE % | 5.15 | |||||
| ROA % | 2.52 | |||||
| ROIC % | 7.87 | |||||
| ROC (Joel Greenblatt) % | 11.13 | |||||
| ROCE % | 10.93 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 24.5 | |||||
| PE Ratio without NRI | 24.5 | |||||
| Shiller PE Ratio | 11.3 | |||||
| PEG Ratio | 0.96 | |||||
| PS Ratio | 0.66 | |||||
| PB Ratio | 1.17 | |||||
| Price-to-Tangible-Book | 1.19 | |||||
| EV-to-EBIT | 11.38 | |||||
| EV-to-EBITDA | 7.9 | |||||
| EV-to-Revenue | 0.89 | |||||
| EV-to-Forward-Revenue | 0.5 | |||||
| EV-to-FCF | -7.7 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.15 | |||||
| Price-to-Graham-Number | 1.15 | |||||
| Price-to-Net-Current-Asset-Value | 42.39 | |||||
| Earnings Yield (Greenblatt) % | 8.78 | |||||
| FCF Yield % | -17.11 | |||||
| Forward Rate of Return (Yacktman) % | 11.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ferozsons Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₨) | 14,516.203 | ||
| EPS (TTM) (₨) | 9.09 | ||
| Beta | 0 | ||
| Volatility % | 49.69 | ||
| 14-Day RSI | 50.21 | ||
| 14-Day ATR (₨) | 6.288308 | ||
| 20-Day SMA (₨) | 224.4 | ||
| 12-1 Month Momentum % | 55.59 | ||
| 52-Week Range (₨) | 132.56 - 256.49 | ||
| Shares Outstanding (Mil) | 43.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ferozsons Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ferozsons Laboratories Ltd Stock Events
| Event | Date | Price(₨) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ferozsons Laboratories Ltd Frequently Asked Questions
What is Ferozsons Laboratories Ltd(KAR:FEROZ)'s stock price today?
The current price of KAR:FEROZ is ₨225.95. The 52 week high of KAR:FEROZ is ₨256.49 and 52 week low is ₨132.56.
When is next earnings date of Ferozsons Laboratories Ltd(KAR:FEROZ)?
The next earnings date of Ferozsons Laboratories Ltd(KAR:FEROZ) is .
Does Ferozsons Laboratories Ltd(KAR:FEROZ) pay dividends? If so, how much?
Ferozsons Laboratories Ltd(KAR:FEROZ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers